Phase I
PreclinicalProtein / enzyme
Phase I is one of 5 biologic programs targeting Premature ovarian insufficiency. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Premature Ovarian Insufficiency
#DrugCompanyPhaseTrials
1Estrace
Novo NordiskApproved
Zoladex
TTerSera Therapeutics LLC
Approved
Activella
Eli LillyPhase 3
Estrasorb
Novo NordiskPreclinical
Phase I
KKK Women's and Children's Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Refractory1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Phase I. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details